01014nam a2200229 i 450099100302636970753620021022144918.0960610s1969 it ||| | ita b1174408x-39ule_instLE021FD224787ExLDip. SSSCita792Ademollo, Alessandro191742I teatri di Roma nel secolo decimosettimo :memorie sincrone, inedite o non conosciute, di fatti ed artisti teatrali, librettisti, commediografi e musicisti, cronologicamente ordinate per servire alla storia del teatro italiano /Alessandro AdemolloBologna :Forni,1969TeatriRomaSec. 17.b1174408x21-09-0624-10-02991003026369707536LE021FD TI19A401LE021FD-2632le023Fondo D'Amico-E0.00-no 00000.i1198395424-10-02Teatri di Roma nel secolo decimosettimo905135UNISALENTOle02110-06-96ma -itait 2105463nam 22007094a 450 991014581460332120200520144314.0978661226783397812822678311282267833978047045185404704518589780470451847047045184X(CKB)1000000000715904(EBL)416234(SSID)ssj0000127579(PQKBManifestationID)11147624(PQKBTitleCode)TC0000127579(PQKBWorkID)10052992(PQKB)11625150(Au-PeEL)EBL416234(CaPaEBR)ebr10297805(CaONFJC)MIL226783(PPN)243326491(FINmELB)ELB178990(OCoLC)352838369(MiAaPQ)EBC416234(Perlego)2756810(EXLCZ)99100000000071590420080923d2009 uy 0engur|n|---|||||txtrdacontentcrdamediacrrdacarrierComputational drug design a guide for computational and medicinal chemists /David C. Young1st ed.Hoboken, N.J. John Wiley & Sonsc20091 online resource (xxxvi, 307 pages) illustrations9780470126851 047012685X Includes bibliographical references and index.COMPUTATIONAL DRUG DESIGN; CONTENTS; PREFACE; ACKNOWLEDGMENTS; ABOUT THE AUTHOR; SYMBOLS USED IN THIS BOOK; BOOK ABSTRACT; 1 Introduction; 1.1 A Difficult Problem; 1.2 An Expensive Problem; 1.3 Where Computational Techniques are Used; Bibliography; PART I THE DRUG DESIGN PROCESS; 2 Properties that Make a Molecule a Good Drug; 2.1 Compound Testing; 2.1.1 Biochemical Assays; 2.1.2 Cell-Based Assays; 2.1.3 Animal Testing; 2.1.4 Human Clinical Trials; 2.2 Molecular Structure; 2.2.1 Activity; 2.2.2 Bioavailability and Toxicity; 2.2.3 Drug Side Effects; 2.2.4 Multiple Drug Interactions2.3 Metrics for Drug-Likeness; 2.4 Exceptions to the Rules; Bibliography; 3 Target Identification; 3.1 Primary Sequence and Metabolic Pathway; 3.2 Crystallography; 3.3 2D NMR; 3.4 Homology Models; 3.5 Protein Folding; Bibliography; 4 Target Characterization; 4.1 Analysis of Target Mechanism; 4.1.1 Kinetics and Crystallography; 4.1.2 Automated Crevice Detection; 4.1.3 Transition Structures and Reaction Coordinates; 4.1.4 Molecular Dynamics Simulations; 4.2 Where the Target is Expressed; 4.3 Pharmacophore Identification; 4.4 Choosing an Inhibitor Mechanism; Bibliography5 The Drug Design Process for a Known Protein Target; 5.1 The Structure-Based Design Process; 5.2 Initial Hits; 5.3 Compound Refinement; 5.4 ADMET; 5.5 Drug Resistance; Bibliography; 6 The Drug Design Process for an Unknown Target; 6.1 The Ligand-Based Design Process; 6.2 Initial Hits; 6.3 Compound Refinement; 6.4 ADMET; Bibliography; 7 Drug Design for Other Targets; 7.1 DNA Binding; 7.2 RNA as a Target; 7.3 Allosteric Sites; 7.4 Receptor Targets; 7.5 Steroids; 7.6 Targets inside Cells; 7.7 Targets within the Central Nervous System; 7.8 Irreversibly Binding Inhibitors7.9 Upregulating Target Activity; Bibliography; 8 Compound Library Design; 8.1 Targeted Libraries versus Diverse Libraries; 8.2 From Fragments versus from Reactions; 8.3 Non-Enumerative Techniques; 8.4 Drug-Likeness and Synthetic Accessibility; 8.5 Analyzing Chemical Diversity and Spanning known Chemistries; 8.6 Compound Selection Techniques; Bibliography; PART II COMPUTATIONAL TOOLS AND TECHNIQUES; 9 Homology Model Building; 9.1 How much Similarity is Enough?; 9.2 Steps for Building a Homology Model; 9.2.1 Step 1: Template Identification9.2.2 Step 2: Alignment between the Unknown and the Template; 9.2.3 Step 3: Manual Adjustments to the Alignment; 9.2.4 Step 4: Replace Template Side Chains with Model Side Chains; 9.2.5 Step 5: Adjust Model for Insertions and Deletions; 9.2.6 Step 6: Optimization of the Model; 9.2.7 Step 7: Model Validation; 9.2.8 Step 8: If Errors are Found, Iterate Back to Previous Steps; 9.3 Reliability of Results; Bibliography; 10 Molecular Mechanics; 10.1 A Really Brief Introduction to Molecular Mechanics; 10.2 Force Fields for Drug Design; Bibliography; 11 Protein Folding; 11.1 The Difficulty of the ProblemHelps you choose the right computational tools and techniques to meet your drug design goals Computational Drug Design covers all of the major computational drug design techniques in use today, focusing on the process that pharmaceutical chemists employ to design a new drug molecule. The discussions of which computational tools to use and when and how to use them are all based on typical pharmaceutical industry drug design processes. Following an introduction, the book is divided into three parts: Part One, The Drug Design Process, sets forth a variety of design processesDrugsDesignMathematical modelsDrugsDesignData processingDrugsDesignMathematical models.DrugsDesignData processing.615/.190285Young David C.1964-514308MiAaPQMiAaPQMiAaPQBOOK9910145814603321Computational Drug Design852152UNINA